Document is current
Any future updates will be listed below
-
Authors
Cerchi, Eduardo https://orcid.org/0000-0001-5500-4701
Santo, Paula Arruda do Espírito
de Oliveira, Mariana Carvalho
Janovsky, Carolina Castro Porto Silva
Halpern, Bruno https://orcid.org/0000-0003-0973-5065
- License Information
-
More Information
Article History
Received: 31 October 2024
Revised: 3 September 2025
Accepted: 18 September 2025
First Online: 27 September 2025
Competing interests
: BH is on the Advisory Board of Novo Nordisk, Eli-Lilly, Astra Zeneca, Merck S/A, and received speaker honoraria from Novo Nordisk, Eli-Lilly, Astra Zeneca, Boehringer Ingelheim, Merck S/A and Abbott Nutrition. BH is Primary Investigator in BrTrials, and has conducted clinical trials by Eli-Lilly, Novo Nordisk and Boehringer Ingelheim. EC, PAES, MCO, and CCPSJ have no conflicts of interest to declare.
